< Back to Article

In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models

Fig 3

The molecular structure of the compounds we considered, based on the pyrido[2,3-d]pyrimidine scaffold (compound family 1).

This family is divided into dimers (1–1 to 1–3) and monomers (1–4 to 1–14).

doi: https://doi.org/10.1371/journal.pone.0178931.g003